Novo Nordisk A/S Common Stock (NVO)
Forex Effect on Cash
-kr 55.00M
TTM · Period ending: · DKK
NVO Forex Effect on Cash
Latest reported-kr 55.00M DKKperiod ending
Latest reported-kr 55.00M DKKperiod ending
NVO TTM Forex Effect on Cash · DKK (-kr 16.46M → -kr 55.00M)
TTM forex effect on cash
High-resolution chart · PNG
NVO forex effect on cash history
Trailing twelve months (TTM) · DKK. Each value covers four complete reported quarters.
| Period ending | Forex Effect on Cash (DKK) |
|---|---|
| -55,000,000 | |
| -917,000,000 | |
| -727,000,000 | |
| -116,000,000 | |
| -527,000,000 | |
| 325,000,000 | |
| 455,000,000 | |
| -471,000,000 | |
| 295,000,000 | |
| 188,000,000 | |
| -119,000,000 | |
| -754,000,000 | |
| -729,000,000 | |
| -446,000,000 | |
| -238,000,000 | |
| 906,000,000 | |
| 585,000,000 | |
| 382,000,000 | |
| 591,000,000 | |
| 140,000,000 | |
| -117,000,000 | |
| -207,000,000 | |
| -456,000,000 | |
| -405,000,000 | |
| -195,000,000 | |
| -180,000,000 | |
| -7,000,000 | |
| 85,000,000 | |
| -19,000,000 | |
| 99,000,000 | |
| 44,000,000 | |
| 70,000,000 | |
| 32,000,000 | |
| -196,000,000 | |
| -211,000,000 | |
| -176,000,000 | |
| -102,000,000 | |
| 115,000,000 | |
| -26,000,000 | |
| -60,000,000 | |
| -109,000,000 | |
| -177,000,000 | |
| 86,000,000 | |
| 71,000,000 | |
| 129,000,000 | |
| 184,000,000 | |
| 68,000,000 | |
| -13,000,000 | |
| -11,000,000 | |
| -69,000,000 | |
| -70,000,000 | |
| -24,000,000 | |
| -33,000,000 | |
| 8,000,000 | |
| -8,000,000 | |
| 34,000,000 | |
| 34,000,000 | |
| 48,000,000 | |
| -16,000,000 | |
| -17,000,000 | |
| -70,000,000 | |
| 59,000,000 | |
| 46,000,000 | |
| 36,000,000 | |
| 78,000,000 | |
| -69,000,000 | |
| 21,000,000 | |
| 30,458,950 | |
| 12,945,700 | |
| 37,770,850 | |
| 4,163,600 | |
| -1,109,450 | |
| 35,835,750 | |
| -12,910,970 | |
| 5,115,300 | |
| 58,129,630 | |
| 46,402,050 | |
| 40,129,370 | |
| 39,554,200 | |
| -21,428,010 | |
| -32,070,580 | |
| 12,951,240 | |
| 151,295,520 | |
| 162,551,630 | |
| 161,832,740 | |
| 109,682,710 | |
| -16,463,430 |